Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 115028
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115028
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.115028
Figure 3 Goosecoid overexpression enhances malignant phenotypes in colorectal cancer cells.
A: Western blotting analysis confirming transduction efficiency of control and goosecoid (GSC)-overexpressing lentiviral vectors in HCT116, HCT8, SW480, and DLD-1 cells; B and C: Colony formation and soft agar assays assessing the proliferative advantage conferred by GSC overexpression; D: Wound healing assay demonstrating accelerated migration in GSC-overexpressing cells. Images of wound closure were taken at the indicated times (0 hour and 48 hours) after scratching. Scale bar, 500 μm; E and F: Transwell migration and invasion assays illustrating the promigratory and pro-invasive effects of GSC overexpression. Scale bar, 100 μm; G: Tube formation assay in HUVECs cultured with conditioned medium from control or GSC-overexpressing colorectal cancer cells. Scale bar, 500 μm. All data represent the mean ± SD from three independent experiments. aP < 0.05, cP < 0.001. GSC: Goosecoid.
- Citation: Li BC, Wang BZ, Han L, Zhang ZW, Wang Y, Zhang YJ, Zhang JN. Goosecoid drives colorectal cancer progression by inducing epithelial-mesenchymal transition. World J Gastrointest Oncol 2026; 18(3): 115028
- URL: https://www.wjgnet.com/1948-5204/full/v18/i3/115028.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.115028